FDA NDC Directory · JSON-LD · Markdown
NDC 46708-744 · HUMAN PRESCRIPTION DRUG · CAPSULE
| Labeler / Manufacturer | Alembic Pharmaceuticals Limited |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA216969 |
| Dosage form / route | CAPSULE · ORAL |
| Active ingredients | CHLORDIAZEPOXIDE HYDROCHLORIDE (5 mg/1) CLIDINIUM BROMIDE (2.5 mg/1) |
| Marketing started | 20231004 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).